Treatment of Gambling Disorder With Fast Acting Opiate Antagonist, Naloxone Nasal Spray

Summary

Non-controlled pilot study. Two groups: Group A: naloxone nasal spray max 8 mg/per day; Group B: naloxone max 16 mg/per day. Study duration 8 weeks. Brief intervention.

Timeline

Start

2017-02-14

Primary completion

2017-06-30

Completion

2017-06-30

Publications

• Dowling N, Merkouris S, Lubman D, Thomas S, Bowden-Jones H, Cowlishaw S. Pharmacological interventions for the treatment of disordered and problem gambling. Cochrane Database Syst Rev. 2022 Sep 22;9(9):CD008936. doi: 10.1002/14651858.CD008936.pub2.

Drugs

Indications